Century Therapeutics, Inc.Century Therapeutics, Inc.Century Therapeutics, Inc.

Century Therapeutics, Inc.

No trades
See on Supercharts

IPSC fundamentals

Century Therapeutics, Inc. earnings per share and revenue

IPSC earnings per share for the last quarter are -0.37 USD whereas the estimation was -0.45 USD which accounts for 17.91% surprise. Company revenue for the same period amounts to 791.00 k USD despite the estimated figure of 440.00 k USD. Estimated earnings per share for the next quarter are -0.41 USD, and revenue is expected to reach 781.83 k USD. Also watch annual changes over time to get a bigger picture of IPSC earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise